| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.2 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.068 | 0.2 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.2 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | JQ-1:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |